Title:
インスリン受容体アクチベーターとしてのベンゼントリカルボン酸誘導対体
Document Type and Number:
Japanese Patent JP2004508348
Kind Code:
A
Abstract:
Compounds of Formula I, and pharmaceutical compositions containing these compounds, activate the insulin receptor kinase, which leads to an increased sensitivity to insulin and an increase in glucose uptake, and are therefore useful for the treatment of animals, especially humans, with hyperglycemia, especially for the treatment of type 2 diabetes. Processes for preparation of the compounds, and their use in assays, are also disclosed.
Inventors:
Louise Robinson
Nicholas Cairns
Prasad buoy buoy s buoy manchem
Stephen Earl Show
Nicholas Cairns
Prasad buoy buoy s buoy manchem
Stephen Earl Show
Application Number:
JP2002525087A
Publication Date:
March 18, 2004
Filing Date:
September 06, 2001
Export Citation:
Assignee:
TERRAPIN TECHNOLOGIES, INC.
International Classes:
A61K31/185; A61K31/192; A61K31/195; A61K31/245; A61P3/10; C07B61/00; C07C231/02; C07C231/12; C07C233/81; C07C235/84; C07C303/22; A61K38/28; C07C309/28; C07C309/51; G01N33/50; G01N33/566; (IPC1-7): C07C233/81; A61K31/185; A61K31/192; A61K31/195; A61K31/245; A61K38/28; A61P3/10; C07C231/02; C07C303/22; C07C309/51
Attorney, Agent or Firm:
Aoyama Aoi
Osamu Kawamiya
Kyousei Tamura
Hiromitsu Takayama
Osamu Kawamiya
Kyousei Tamura
Hiromitsu Takayama